
HUMIRA
40mgHUMIRA40mg
HUMIRA (adalimumab) is a TNF inhibitor for rheumatoid arthritis, psoriasis, Crohn's disease, and other inflammatory conditions.
Key Benefits
- Leading TNF inhibitor
- Multiple approved indications
- Self-injection convenience
- Proven long-term safety
Contact Us for Pricing
Get a written quote against a prescription within 24 hours for HUMIRA 40mg. Our team is available 24/7.
Direct line: +44 7429 917553
Prescription required
We do not proceed without one
Licensed Türkiye channels
İTS serial-traceable by karekod
Delivered in person
Not shipped by courier
Written reply
Quote within 24 hours
About HUMIRA 40mg
HUMIRA (adalimumab) 40mg is the world's leading TNF-alpha inhibitor biologic, manufactured by AbbVie for treating a wide range of inflammatory and autoimmune conditions. This subcutaneous injection works by neutralizing tumor necrosis factor alpha, a key driver of inflammation. HUMIRA is approved for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, and more. We provide genuine HUMIRA with complete documentation, proper cold chain handling, and a written quote against a prescription, usually within 24 hours for global distribution.
Common Uses
- Rheumatoid arthritis
- Psoriatic arthritis
- Crohn's disease
- Plaque psoriasis
- Ulcerative colitis


